ADORA2A and Parkinson disease: In this study, a series of novel adenosine A2A receptor antagonists with 1H-pyrazolo [3,4-d]pyrimidin-6-amine core scaffolds was designed and synthesized as potential anti-Parkinson’s disease agents using efficient synthetic methods with three-step short routes.